Stephen G Ellis MD
Adult Congenital Heart Disease, Interventional Cardiology
Professor of Medicine Section Head/Interventioanl Cardiology Cleveland Clinic
Join to View Full Profile
9500 Euclid AveCleveland, OH 44195
Phone+1 216-445-6712
Fax+1 216-445-6714
Dr. Ellis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Emory University School of MedicineFellowship, Cardiovascular Disease, 1985 - 1986
Stanford Health Care-Sponsored Stanford UniversityFellowship, Cardiovascular Disease, 1982 - 1985
Mass General Brigham/Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1981 - 1982
Cedars-Sinai Medical CenterResidency, Internal Medicine, 1978 - 1981
David Geffen School of Medicine at UCLAClass of 1978
Certifications & Licensure
OH State Medical License 1991 - 2027
CA State Medical License 2002 - 2026
NY State Medical License 2002 - 2020
IL State Medical License 2002 - 2017
PA State Medical License 2002 - 2016
MI State Medical License 1986 - 1993
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2011, 2013-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013-2017
Clinical Trials
- A Phase I - II Safety Study of Filgrastim (Neupogen) to Improve Left Ventricular Function After Severe Acute Myocardial Infarction
- Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis Start of enrollment: 2003 Jun 01
- TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent Start of enrollment: 2002 Mar 01
Publications & Presentations
PubMed
- Predicting LVEF After PCI and its Effect on Clinical Outcomes in Patients With Stable Ischemic Cardiomyopathy and LVEF≤50.Stephen G Ellis, Ben Alencherry, Khaled Ziada, Jacqueline Tamis-Holland, Evan Whitehead
The American Journal of Cardiology. 2026-01-15 - The New Clinical Interface: Information Retrieval and Reasoning With LLMs.Mohamad Alkhouli, Stephen G Ellis
JACC. Cardiovascular Interventions. 2025-10-27 - Blood Draws, Fluid Input, and Bleeding Events After Percutaneous Coronary Intervention.Meghana Iyer, Ankur Kalra, Khaled Ziada, Jacqueline Tamis-Holland, Leslie Cho
Catheterization and Cardiovascular Interventions. 2025-09-01
Press Mentions
ABSORB III: 5-Year Results Offer Renewed Hope for Bioresorbable StentsSeptember 26th, 2019
EuroCTO CASTLE: Prediction Model for CTO PCI Success Shows Good Discriminating AbilityFebruary 4th, 2019
Revascularization for Silent Ischemia Linked to Better OutcomesJanuary 17th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
